June 22, 2020 / 11:04 AM / 17 days ago

BRIEF-G1 Therapeutics And Genor Biopharma Announce Exclusive License Deal For Lerociclib In Asia-Pacific Region

June 22 (Reuters) - G1 Therapeutics Inc:

* G1 THERAPEUTICS AND GENOR BIOPHARMA ANNOUNCE EXCLUSIVE LICENSE AGREEMENT FOR LEROCICLIB IN ASIA-PACIFIC REGION

* G1 THERAPEUTICS INC - G1 TO RECEIVE $6 MILLION UPFRONT PAYMENT

* G1 THERAPEUTICS INC - G1 TO RECEIVE UP TO $40 MILLION IN FUTURE MILESTONE PAYMENTS

* G1 THERAPEUTICS INC - GENOR WILL PAY G1 TIERED ROYALTIES RANGING FROM HIGH SINGLE TO LOW DOUBLE-DIGITS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below